tiprankstipranks
Scandinavian ChemoTech AB Class B (SE:CMOTEC.B)
:CMOTEC.B
Sweden Market
CMOTEC.B
Scandinavian ChemoTech AB Class B
RESEARCH TOOLSreports
Want to see SE:CMOTEC.B full AI Analyst Report?

Scandinavian ChemoTech AB Class B (CMOTEC.B) Income Statement

0 Followers

Scandinavian ChemoTech AB Class B Income Statement

Last quarter (Q2 2025), Scandinavian ChemoTech AB Class B's total revenue was kr3.84M, an increase of 128.49% from the same quarter last year. In Q2, Scandinavian ChemoTech AB Class B's net income was kr-943.00K. See Scandinavian ChemoTech AB Class B’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 12.29Mkr 6.57Mkr 2.82Mkr 473.00Kkr 49.00K
Gross Profit
kr -6.30Mkr 4.78Mkr 1.66Mkr -55.00Kkr 323.00K
Operating Expenses
kr 0.00kr 17.57Mkr 21.89Mkr 20.86Mkr 19.94M
Depreciation and Amortization
kr 1.97Mkr 163.00Kkr 109.00Kkr 41.00Kkr 42.00K
EBITDA
kr -4.33Mkr -12.38Mkr -19.58Mkr -20.81Mkr -17.03M
Operating Income
kr -6.30Mkr -12.80Mkr -20.24Mkr -20.91Mkr -17.08M
Other Income/Expenses
kr -1.75Mkr -921.00Kkr -854.00Kkr -1.83Mkr -666.00K
Pretax Income
kr -8.06Mkr -13.72Mkr -21.09Mkr -22.75Mkr -17.74M
Net Income
kr -8.06Mkr -13.72Mkr -21.09Mkr -22.75Mkr -17.74M
Per Share Metrics
Basic EPS
kr -0.34kr -0.59kr -1.50kr -2.28kr -2.05
Diluted EPS
kr -0.34kr -0.59kr -1.50kr -2.28kr -2.05
Weighted Average Shares Outstanding
 24.03M 23.34M 14.04M 9.97M 8.66M
Weighted Average Shares Outstanding (Diluted)
 24.03M 23.34M 14.04M 9.97M 8.66M
Currency in SEK

Scandinavian ChemoTech AB Class B Earnings and Revenue History